ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,279, issued on June 24, was assigned to Scholar Rock Inc. (Cambridge, Mass.).
"Selective and potent inhibitory antibodies of myostatin activation" was invented by Christopher Chapron (Cambridge, Mass.), Frederick C. Streich Jr. (Cambridge, Mass.), Kaleigh Canonico (Cambridge, Mass.), Shaun M. Cote (Cambridge, Mass.), Francis Danehy Jr. (Cambridge, Mass.), Melissa Fulham (Cambridge, Mass.), Yan Huang (Cambridge, Mass.), Justin William Jackson (Cambridge, Mass.), Mania Kavosi (Cambridge, Mass.) and Sandeep Kumar (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibodies and antigen-binding fragments t...